SCHEMBL23197837

SCHEMBL23197837

COc1c(C)c(C(C)=O)nc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
MAPT P10636 2/20 0.46
TP53 P04637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
HTT P42858 2/20 0.44
ALOX15 P16050 1/20 0.44
PDE10A Q9Y233 1/20 0.44
KDM4E B2RXH2 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
IDO1 P14902 1/20 0.43
GLA P06280 1/20 0.42
CDK9 P50750 1/20 0.42
DYRK1A Q13627 1/20 0.42
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8569894 0.84 POLB (0.51) POLBMAPTMEN1KMT2AHTT
SCHEMBL23197838 0.82 POLB (0.50) POLBMAPTMEN1KMT2AHTT
SCHEMBL23197722 0.77 POLB (0.63) POLBMAPTMEN1KMT2AHTT
SCHEMBL23999688 0.76 POLB (0.68) POLBMAPTTP53HSD17B10MEN1
SCHEMBL21940223 0.75 HSD17B10 (0.60) POLBMAPTTP53HSD17B10MEN1
SCHEMBL4272933 0.75 POLB (0.66) POLBMAPTKMT2AHTTKDM4E
SCHEMBL753481 0.75 POLB (0.51) POLBMAPTTP53MEN1KMT2A
SCHEMBL8571831 0.75 POLB (0.41) POLB
SCHEMBL23197724 0.73 POLB (0.63) POLBMAPTMEN1KMT2AKDM4E
SCHEMBL1408391 0.73 POLB (1.00) POLBMAPTTP53HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220389008-A1 4-QUINOLINONE ANTIBACTERIAL COMPOUNDS Janssen Sciences Ireland Unlimited Company (IE) 2022-12-08 US disclosed
US-20220372033-A1 ANTIBACTERIAL COMPOUNDS Janssen Sciences Ireland Unlimited Company (IE) 2022-11-24 US disclosed
WO-2021063914-A1 4-QUINOLINONE ANTIBACTERIAL COMPOUNDS Janssen Sciences Ireland Unlimited Company (IE) 2021-04-08 WO disclosed
WO-2021063915-A1 ANTIBACTERIAL COMPOUNDS Janssen Sciences Ireland Unlimited Company (IE) 2021-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220372033-A1 ANTIBACTERIAL COMPOUNDS NDUFS3, SQOR, MT-ND4 POLB 417/4885MAPT 1796/4885TP53 3192/4885
US-20220389008-A1 4-QUINOLINONE ANTIBACTERIAL COMPOUNDS NQO2, NDUFS3, QARS1 POLB 641/4885MAPT 2027/4885TP53 2748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.